Evaluation of effect of Inj. ENOXAPARIN on postoperative inflammation after cataract surgery in lens induced glaucoma patients.

EVALUATION OF EFFECT OF INTRACAMERAL ENOXAPARIN ON POST-OPERATIVE INFLAMMATION IN LENS INDUCED GLAUCOMA : A PROSPECTIVE AND COMPARATIVE STUDY

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008460

Enrollment

Registered

2017-05-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with lens induced glaucoma..

Interventions

Intervention1: Injection ENOXAPARIN: Injection given in patients with lens induced glaucoma intraoperatively and follow up examination to see post operative inflammation Control Intervention1: nil: ni

Eligibility

Inclusion criteria

Inclusion criteria: Patients who him or herself are giving written and informed consent for participation in the study. Diagnosis of intumescent lens or phacomorphic glaucoma,associated with intraocular pressure more than 21 mmHg or Shallow anterior chamber or Closed chamber angle or Lack of any previous surgical or laser intervention. Diagnosis of phacolytic glaucoma with raised IOP, conjunctival congestion, diffuse corneal edema, associated with severe anterior chamber inflammation in terms of flare and cells. Diagnosis of phacoanaphylactic glaucoma. Patients who are participating in the study who undergone uneventful cataract surgery.

Exclusion criteria

Exclusion criteria: Patients who require pre or postoperative antiinflammatory agents other than Enoxaparin either in topical or systemic formulation. Preexisting pathology in eye eg. corneal, macular or optic nerve disorders, active infection of any structure of eye Patients who are not giving written and informed consent for participation in the study.

Design outcomes

Primary

Measure	Time frame
All the patients will be examined for postoperative inflammation in terms of cells, flare and fibrinous membrane in anterior chamber and grading will be given according to SUN WORKING GROUP OF CLASSIFICATION. Data entry will be done in Microsoft excel 2010 & analysed according to Mann Whitney â??Uâ?? Test. Timepoint: All the patients will be examined for total 6 weeks of post-operative period at interval of postoperative Day1, day3, 1st week, 2nd week, 4th week & 6th week.	—

Measure

Time frame

All the patients will be examined for postoperative inflammation in terms of cells, flare and fibrinous membrane in anterior chamber and grading will be given according to SUN WORKING GROUP OF CLASSIFICATION. Data entry will be done in Microsoft excel 2010 & analysed according to Mann Whitney â??Uâ?? Test. Timepoint: All the patients will be examined for total 6 weeks of post-operative period at interval of postoperative Day1, day3, 1st week, 2nd week, 4th week & 6th week.

—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Nilesh V Parekh

GOVT MEDICAL COLLEGE BHAVNAGAR

drnvparekh@hotmail.com09428408788

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026